Hansen Medical (NASDAQ:HNSN) develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies.
Insider buying during the last 30 days
Here is a table of Hansen Medical's insider activity during the last 30 days.
|Name||Title||Trade Date||Shares Purchased||Current Ownership||Increase In Shares|
|Marjorie Bowen||Director||May 13||9,789||87,780 shares||+12.6%|
|Michael Eagle||Director||May 13||10,000||26,250 shares||+61.5%|
|Stephen Newman||Director||May 13||8,000||128,821 shares||+6.6%|
|Nadim Yared||Director||May 13||2,143||22,216 shares||+10.7%|
There have been 29,932 shares purchased by insiders during the last 30 days.
Insider buying by calendar month
Here is a table of Hansen Medical's insider activity by calendar month.
|Month||Insider buying / shares||Insider selling / shares|
There have been 9,670,943 shares purchased and there have been 165,289 shares sold by insiders since January 2013.
Hansen Medical reported the first-quarter financial results on May 7 with the following highlights:
|Net loss||$14.4 million|
The four insiders purchased their shares after these results.
|Qtrly Rev Growth (yoy):||0.25||0.03||-0.24|
|PEG (5 yr expected):||0.02||2.52||11.52|
Hansen Medical has the fastest revenue growth among these three companies.
Here is a table of these competitors' insider activities this year.
|Company||Insider buying / shares||Insider selling / shares|
Only Hansen Medical has seen intensive insider buying during the last 30 days.
There have been four different insiders buying Hansen Medical, and there have not been any insiders selling Hansen Medical during the last 30 days. Three of these four insiders increased their holdings by more than 10%. Hansen Medical has an insider ownership of 22.76%.
The four insiders purchased their shares at prices ranging from $1.19 to $1.27. I believe Hansen Medical could be a good pick below $1.27 based on the intensive insider buying.
Disclosure: I have no positions in any stocks mentioned, but may initiate a long position in HNSN over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.